<DOC>
	<DOCNO>NCT02242331</DOCNO>
	<brief_summary>This post-marketing surveillance study design supplement condition normal clinical practice data safety , tolerability efficacy Micardis® collect clinical study special emphasis control blood pressure morning intake next antihypertensive drug</brief_summary>
	<brief_title>Post-marketing Study Supplement Data Safety , Tolerability Efficacy Micardis® With Special Emphasis Control Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Essential hypertension At least 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>